SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-20-018704
Filing Date
2020-06-03
Accepted
2020-06-03 16:16:27
Documents
1
Period of Report
2020-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 2982
  Complete submission text file 0001127602-20-018704.txt   4473
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 280 S. MANGUM STREET SUITE 350 DURHAM NC 27701
Business Address
INGRAM ROBERT ALEXANDER (Reporting) CIK: 0001219890 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 20940191